Literature DB >> 22771216

Association of tissue plasminogen activator and plasminogen activator inhibitor polymorphism with myocardial infarction: a meta-analysis.

Li-Li Gong1, Jian-Hao Peng, Fei-Fei Han, Jin Zhu, Lian-Hua Fang, Yue-Hua Wang, Guan-Hua Du, He-Yao Wang, Li-Hong Liu.   

Abstract

INTRODUCTION: To investigate whether t-PA Alu repeat insertion/deletion (I/D) and PAI-1 4G/5G genetic variations are associated with the risk of MI.
METHODS: We conducted a meta-analysis to assess the association between the t-PA I/D and PAI-1 4G/5G polymorphisms and risk of MI. We also performed subgroup analyses based on ethnicity (Caucasian, Asian, and African), gender and age. Forty one eligible studies including 12,461 cases and 14,993 controls were identified to evaluate the impact of PAI-1 4G/5G polymorphism on MI. Seven studies investigated the relationship between t-PA I/D and MI.
RESULTS: This meta-analysis revealed that the PAI-1 4G allele (4G/4G and 4G/5G genotype) was associated with an increased risk of MI compared with the 5G allele in the overall population (OR=1.094, 95% CI=1.021 - 1.172, p=0.011). The relative risks of MI for 4G/4G genotype was increased when compared to 5G/5G genotype and 5G allele, with odds ratio at 1.157 (95% CI 1.015 - 1.320, p=0.029) and 1.126 (95% CI =1.015 - 1.249, p=0.025). However, the results show that the 4G/5G polymorphism risk for MI was not associated with ethnicity stratification as Caucasian, Asian or African population. No substantial differences in the genotype distributions were observed in the MI group and control group along the lines of gender and age. After multivariable analysis t-PA I/D polymorphism showed no consistent association with MI.
CONCLUSIONS: This study suggests that the 4G/5G polymorphism of PAI-1 may be a risk factor for MI in overall populations.
Copyright © 2012 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22771216     DOI: 10.1016/j.thromres.2012.06.015

Source DB:  PubMed          Journal:  Thromb Res        ISSN: 0049-3848            Impact factor:   3.944


  11 in total

1.  PAI-1 Inhibition - Another Therapeutic Option for Cardiovascular Protection.

Authors:  Monica Mariana Baluta; Marius Marcian Vintila
Journal:  Maedica (Buchar)       Date:  2015-06

2.  Association between the rs6950982 polymorphism near the SERPINE1 gene and blood pressure and lipid parameters in a high-cardiovascular-risk population: interaction with Mediterranean diet.

Authors:  Mercedes Sotos-Prieto; Marisa Guillén; Olga Portolés; José V Sorlí; José I González; Eva M Asensio; Dolores Corella
Journal:  Genes Nutr       Date:  2012-12-09       Impact factor: 5.523

Review 3.  Association Between Plasminogen Activator Inhibitor-1 Genetic Polymorphisms and Stroke Susceptibility.

Authors:  Xin Hu; Xin Zan; Zhiyi Xie; Yunke Li; Sen Lin; Hao Li; Chao You
Journal:  Mol Neurobiol       Date:  2016-01-07       Impact factor: 5.590

4.  A Case of Unexplained Cerebral Sinus Thrombosis in a 22-Year-Old Obese Caucasian Woman.

Authors:  Jansen N Seheult; Irina Chibisov
Journal:  Lab Med       Date:  2016-06-10

Review 5.  Hemostatic factors and risk of coronary heart disease in general populations: new prospective study and updated meta-analyses.

Authors:  Peter Willeit; Alexander Thompson; Thor Aspelund; Ann Rumley; Gudny Eiriksdottir; Gordon Lowe; Vilmundur Gudnason; Emanuele Di Angelantonio
Journal:  PLoS One       Date:  2013-02-07       Impact factor: 3.240

6.  Endothelial nitric oxide synthase gene G894T polymorphism and myocardial infarction: a meta-analysis of 34 studies involving 21,068 subjects.

Authors:  Jian-Quan Luo; Jia-Gen Wen; Hong-Hao Zhou; Xiao-Ping Chen; Wei Zhang
Journal:  PLoS One       Date:  2014-01-30       Impact factor: 3.240

7.  Type 1 plasminogen activator inhibitor as a common risk factor for cancer and ischaemic vascular disease: the EPICOR study.

Authors:  Licia Iacoviello; Claudia Agnoli; Amalia De Curtis; Augusto di Castelnuovo; Maria Concetta Giurdanella; Vittorio Krogh; Amalia Mattiello; Giuseppe Matullo; Carlotta Sacerdote; Rosario Tumino; Paolo Vineis; Giovanni de Gaetano; Salvatore Panico; Maria Benedetta Donati
Journal:  BMJ Open       Date:  2013-11-14       Impact factor: 2.692

8.  Etiopathogenesis of Sheehan's Syndrome: Roles of Coagulation Factors and TNF-Alpha.

Authors:  Halit Diri; Elif Funda Sener; Fahri Bayram; Nazife Tascioglu; Yasin Simsek; Munis Dundar
Journal:  Int J Endocrinol       Date:  2014-04-10       Impact factor: 3.257

9.  Association of G894T eNOS, 4G/5G PAI and T1131C APOA5 polymorphisms with susceptibility to myocardial infarction in Morocco.

Authors:  Hind Hassani Idrissi; Wiam Hmimech; Brehima Diakite; Farah Korchi; Dalila Baghdadi; Rachida Habbal; Sellama Nadifi
Journal:  Meta Gene       Date:  2016-04-03

Review 10.  Puzzling role of genetic risk factors in human longevity: "risk alleles" as pro-longevity variants.

Authors:  Svetlana Ukraintseva; Anatoliy Yashin; Konstantin Arbeev; Alexander Kulminski; Igor Akushevich; Deqing Wu; Gaurang Joshi; Kenneth C Land; Eric Stallard
Journal:  Biogerontology       Date:  2015-08-26       Impact factor: 4.277

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.